Keros Therapeutics Insider Sales: Routine Tax Moves, No Panic Detected
Insider sales at Keros Therapeutics are routine “sell‑to‑cover” tax‑withholding moves, not a sign of panic, leaving the company’s biotech prospects intact.
2 minutes to read
Keros Therapeutics Inc